Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Yogev

Showing results (131-140 of 170) with videos related to

Pageof 17
Sort By:
Antimicrobial Agents and Chemotherapy|February 27, 1999
Safety and single-dose pharmacokinetics of abacavir (1592U89) in human immunodeficiency virus type 1-infected childrenW Hughes, J A McDowell, J Shenep, et al.
Antimicrobial Agents and Chemotherapy|May 29, 1999
Pharmacokinetics of azithromycin administered alone and with atovaquone in human immunodeficiency virus-infected children. The ACTG 254 TeamL Y Ngo, R Yogev, W M Dankner, et al.
The Journal of Infectious Diseases|December 1, 1995
Phase I evaluation of zalcitabine administered to human immunodeficiency virus-infected childrenE G Chadwick, L A Nazareno, T J Nieuwenhuis, et al.
The Pediatric Infectious Disease Journal|September 1, 1989
Varicella-zoster virus infections in children infected with human immunodeficiency virusE Jura, E G Chadwick, S H Josephs, et al.
Pediatrics|October 1, 1988
Haemophilus influenzae type b immunization of children with sickle cell diseasesA L Frank, R J Labotka, S Rao, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1995
Sequential, single-dose pharmacokinetic evaluation of meropenem in hospitalized infants and childrenJ L Blumer, M D Reed, G L Kearns, et al.
The Journal of Pediatrics|January 1, 1991
Immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in 3- to 17-month-old infants with sickle cell diseasesJ F Marcinak, A L Frank, R L Labotka, et al.
Antimicrobial Agents and Chemotherapy|June 13, 1998
Phase I safety and pharmacokinetics study of micronized atovaquone in human immunodeficiency virus-infected infants and children. Pediatric AIDS Clinical Trials GroupW Hughes, A Dorenbaum, R Yogev, et al.
The Journal of Clinical Investigation|February 13, 2001
Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting womenB K Patterson, H Behbahani, W J Kabat, et al.
JAMA|June 20, 1990
Tumors of smooth-muscle origin in HIV-infected childrenE G Chadwick, E J Connor, I C Hanson, et al.
Pageof 17

Showing results (131-140 of 170) with videos related to

Sort By:
Pageof 17
Antimicrobial Agents and Chemotherapy|February 27, 1999
Safety and single-dose pharmacokinetics of abacavir (1592U89) in human immunodeficiency virus type 1-infected childrenW Hughes, J A McDowell, J Shenep, et al.
Antimicrobial Agents and Chemotherapy|May 29, 1999
Pharmacokinetics of azithromycin administered alone and with atovaquone in human immunodeficiency virus-infected children. The ACTG 254 TeamL Y Ngo, R Yogev, W M Dankner, et al.
The Journal of Infectious Diseases|December 1, 1995
Phase I evaluation of zalcitabine administered to human immunodeficiency virus-infected childrenE G Chadwick, L A Nazareno, T J Nieuwenhuis, et al.
The Pediatric Infectious Disease Journal|September 1, 1989
Varicella-zoster virus infections in children infected with human immunodeficiency virusE Jura, E G Chadwick, S H Josephs, et al.
Pediatrics|October 1, 1988
Haemophilus influenzae type b immunization of children with sickle cell diseasesA L Frank, R J Labotka, S Rao, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1995
Sequential, single-dose pharmacokinetic evaluation of meropenem in hospitalized infants and childrenJ L Blumer, M D Reed, G L Kearns, et al.
The Journal of Pediatrics|January 1, 1991
Immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in 3- to 17-month-old infants with sickle cell diseasesJ F Marcinak, A L Frank, R L Labotka, et al.
Antimicrobial Agents and Chemotherapy|June 13, 1998
Phase I safety and pharmacokinetics study of micronized atovaquone in human immunodeficiency virus-infected infants and children. Pediatric AIDS Clinical Trials GroupW Hughes, A Dorenbaum, R Yogev, et al.
The Journal of Clinical Investigation|February 13, 2001
Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting womenB K Patterson, H Behbahani, W J Kabat, et al.
JAMA|June 20, 1990
Tumors of smooth-muscle origin in HIV-infected childrenE G Chadwick, E J Connor, I C Hanson, et al.
Pageof 17